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20. Thrornbin generation, an essential step
in haemostasis and thrornbosis
H. C. Hemker
Thrombin (EC3.4.21 .5)  is  rhe cenrra l  b ioregularorv en-
4 'me in haemosrasis .  I f  funcr ions ar  rhe level  of  the
piasma, the p lare ler  and rhe vessei  ' "va l l  and has a lso some
acuons less obvrously re lated to haemostasis .  In  th is
chaprer  we wi l l  do rwo th ings:  del ineare i rs  ro le in  hae-
mostasis  and thrombosis and descnbe rhe mechanism of
thrombin formation. Doing so u'e u.i l l  necessaril l '  rouch
upon parr  of  the marer ia l  thar  is  r reated in  more deta i l
in  other  chapters.  Yer  rhe derai led d iscussion of  rhe indr-
v idual  facrors,  react ions and d iseaseJmay not  auromat i -
ca l ly  lead to recogniuon of  rhe organised inrerp lay
berween the elemenrs of rhis biochemical sysrem in rvhich
thrombin p lays the p ivora l  ro le.  Posi t ive and negar ive
feedback reacr ions,  rhe cooperat ion between p lare lers and
soluble factors, florv and surfaces, rogether govern rhrombin
formadon at the site of a '"vound or a thrombus. \I/e wil l
try to g'lve a picture of this sysrem as a whole and ro define
i rs  p lace in  haemosrar ic  and rhromboi ic  evenrs.  \ \ /e  refer
to the speci f ic  chapters for  the manv derai is  thar  r r ,e  must
necessarily menrion only in passing.
Tradidonal ly  the haemosrar ic  process is  d iv ided into
rhree stages:
l. Formauon of rhe pnmary plareler plug: rhe reacrion of
plateiets r.rrth rhe subendorhelial inrersdtium makes
them form an r.rnstable plug
2. Stabil izarion of the pnmary plug: thrombin converrs
fibnnogen to hbrin, u'hich cements together the loose
plug and seals the vessel
3. Fibrinolysis: plasmtn dissolves the hbnn srrands ur rhe
course of wound healing
Often the recognir ion of  these stages is  rhe basis  of  a
s impi i f ied concepr in  which pr imary haemosrasrs com-
pr ises a l l  the p late let  react ions u 'hereas secondar l '  hae-
mostasis  is  ident i f ied wirh coaguiarron.  By extension rh is
leads to the concepr of  an ar ter ia l  thrombus being a k ind
of  pnmarv p lug thar  ar ises by p lare ler  acdon only,  u ' i rhour
tnvolvement  of  the c lot t ing svstem rvhereas a venous
thrombus would resemble a b lood c lor .  The idea,  popular
in the 1960s and 1970s,  rhar  arrer ia l  rhrombosis should be
sensi t ive ro anr ip late ler  drugs only and insensi r ive to
antrcoagulanrs is easily grafted upon rhis misconceprion.
The importance of thrombin generarion was maintained
by some (e.g.  Hemker 1975),  bur  oni f  in  1980 when rhe
group of Loeliger published rhe sxry-plus reinfarction
stud-v was a change in opinion was iniriared (see Meade
1984). Now we wirness an increasing inrerest in thrombin-
medrared reactions and their role in haemostasis and
thrombosis. A posteriori, i t seems oniy natural to recog-
nise thar thrombin generarion, plarelet reacdons and
vessel reacrions cooperare closely in all forms of haemos-
tas is  and rhrombosis.  Thrombin is  rhe mosr porenr  p lare-
let  act ivator  and acr ivared p lare lets  are cruc ia l  in  causing
explosive thrombin generarion. The components of rhe
haemostar ic  mechanism do nor  operare in  a sequence of
solo performances bur rather in concerr wirh each other,
each mechanism alrernarely taking the front bur never
wi thout  the accompanimenr of  the orhers.
THE ROLES OF THROMBIN
Thrombin and thrombosis
The two t1 'pes of  anr icoagulant  rearment ,  hepar in and
oral anticoagularion, are so differenr in their mode of
action as well as in rheir side-effects rhar it can be safely
assumed thar rvhere rhey share an effecr, rhis is because of
the only knor.r'n properry thar they' have in common:
drminudon of the amounr of thrombin rhar is generared in
c lotdng p lasma
Many rrials have shou'n thar anticoagulanon is an effi-
caclous trearmenr in different rypes of venous rhrombosis
rvhereas anriplarelet agenrs are nor or are hardly effective
(Hirsh I986)  The more in teresr ing quest ion is  whether
antrcoagular ion rnhib i rs  ar ter ia l  thrombosis,  because,  i f
i t does, this shorvs rhat rhrombin plays a role in rhe
format ion of  a p lare ler  thrombus.
The Dutch sixry-plus rrial and rhe Norwegran \7ARIS
srudy (Sixry-plus Reinfarcrion Srudl' Research Group
1980,  Smirh et  a l  1990) showed rhar  ora l  anr icoagula-
tion can prevenr recurrent myocardial infarcrion. More
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recent ly  i t  has been shown rhat  hepann r rearmenr can do
the same (I.. ieri-Semeri er al 1990). Aspirin is also pre-
ventative bur comparison of the figures suggesrs rhat ir is
nor more effective than adequate anricoagularion (Pero er
a l  1988,  Steer ing Commit tee of  rhe Physic ians Healrh
Study Group 1989).
There seems to be no doubt  that  anr ip late let  herapy
such as aspirin reduces morraliry in unsrable anglna
( I -eu ' rs  1983,  Cairns 1985,  Kenns & Fi rzGerra ld l99l )
and in myocardial infarcrion (Antiplateler Tnalisrs
Col laborat ion 1988) but  hepar in appears ar  leasr  as
effectrve (fheroux I988, Rrsk Group 1990).
In expenmental rhrombosis borh oral anricoagulation
and heparin diminish venous as well as arterial thrombo-
s is .  Inauen et  a l  (1990,  1991) per formed exper imenrs in
which blood from hurnan volunreers u'as passed over rhe
subendothelium of rabbit aorta ar differenr rares. At lo'"r '
(venous) florv rates, f ibrin deposition is rhe predominanr
phenomenon.  I t  is  prevented in a dose:dependenr manner
b1" heparin and ar lou' levels of oral anricoagulation
( :50" / ,  inh ib i t ion at  an INR| o i  -  2) .  Ar  h igh (arrer ia l ;
f lou '  rates,  p late let  deposi r ion rs  rhe predominanr phe-
nomenon.  l t  can be inhib i ted bv inrense ora l  anr icoagula-
t ion ( INR 5.2)  but  is  bare ly  af fecred bv hepann.  Hirudrn
however inhib i ts  exper imenta l  thrombosis in  p igs under
c i rcumstances where hepar in is  inef fecrrve (Badimon er  a l
l99 l ) .  On the whole,  exper imenral  ar ter ia l  rhrombosis
responds wel l  to  rhrombin inhrb i r ion (Sreel  er  a l  1985,
B a d i m o n  e t  a l  1 9 8 6 ,  1 9 8 7 ,  1 9 8 8 ,  I 9 9 1 ,  L a m  e r  a l  1 9 8 6 ,
Cheseb ro  e t  a l  1987 ,  He ras  e r  a l  l 98S) .  I r  has  a l so  been
demonsrared that, in an arrerial rhrombosis model, picreler-
dependent  thrombosis can be prevenied b1 '  rhrombin in-
h ib i t ion ur th s-vnthet ic  thrombin inhib i rors,  h i rudin and
di f ferent  r1 'pes of  hepann (Cadrol '  er  a l  1989) bur  ant i -
bodies againsr  the GPIIb/ I I Ia  complex of  the phreler
membrane are a iso ef fecdve,  as rs  aspi r in  (Hanson &
Harke r  1988 ,  Hanson  e t  a l  1988 ,  Grube r  e r  a l  1989 ) .
Suggestive evidence for a role of thrombin Elenerarion in
the genesis of  coronary in farcr ion has been obta ined b1 '
Meade et  a l  (1986).  They showed rhat  an increase of  rhe
clotdng factors I ,  VI I  and VI I  predrcrs a f i rsr  coronan'
in farct ion wi th even more cer ta inn Ihan rhe cholesrero l
level  does.  Factors I  and VI I I  are acure phase prore ins rhar
mighr rise u'ith any rype of i l lness or srress and rhus
may be s imply accompanying phenomena wirhour  causal
re iat ronship wi th the rhrombosis rhat  is  ro come. For
factor  VI I  t r  is  much more d i f f icu l r  ro exclude a causal
re lat ionship.
One cannot  escape the conclusron rhar  in  the genera-
tion of the arterial thrombus, both in humans and in
r N l {  =  l n t e m a t r o n a l  N o r m a l i z c d  l t r t r . r  = ' [ ' h c  r a t r r t  o l  l h c  n r o t h r r r n r l r r n
t in re  o f  the  paucnt  ovcr  tha t  o l  a  normal  con l ro l  p idsmu cor rcc tcd  ln
s u c h  a  w a y  a s  L o  m a k e  i t  i n d e p e n d c n t  ( l l  t h c  t v p c  ( ) l  t h r ( ) n l l ) r l p l r s t l n
u  sed
expenmental animals, thrombin plays as important a role
as platelers do. This conclusion is only in apparent contra-
d ic t ion u ' i th  the observadon that  p late ler  hyperreacdvi ry ,
as observed by spontaneous aggregation in vitro, is a use-
ful biologcal marker for the prediction of coronary evenrs
ffrip er al 1990). Plarelet reacdviry may be a step in
rhrombotic events that is harmless if not followed by
thrombin formation, or thrombin formation may be a step
in the mechanism of spontaneous aggregation, even in
ant icoagulated b lood (see p.  ooo; .
Thrombin and the bleeding time
Haemophil iacs have a bleeding rendency but their pri-
mary bleeding rime is generally considered ro be normal.
Thrombopenias and thrombopathies, on the contrary,
show a markedly pro longed b leeding t ime.  This has led
to the general ly  accepred idea that  rhe b leedrng t ime is
determined b-v the efficacy of primary plug formation and
therefore is a coagulation-independent phenomenon. There
are reports however that defrciencies in factors I, V and
\ / l l  cause a s l ight lv  pro longed b leeding t ime (Eyster  er  a l
l 98 l ) -  Seconda r l ' b l eed ing ,  i . e .  t he  b leed ing  o f  a  reopened
rvound (Borchgrevink & Wal ler  1958),  is  pro longed in
haernophii ia and clearl-. i dependent upon thrombin for-
mat ion.  The analogv rv i th  arrer ia l  and venous thrombosis
rs obvious,  bur  the issue rs more d i f f icuk to solve.
Bleedrng t ime determinat ions are notor iously  imprecise
ano s l ight  pro longarrons are d i fhcul t  to  demonstrate wrth
the requi red star is t ica l  s ignihcance.  AIso i t  is  not  immedi-
ate i l '  c lear  rvhether  a g iven expenmental  model  represents
pr lmar! '  or  secondan'  haemosrasis .  In  haernophi l iac dogs
the cut icu la b leeding r ime is  pro longed (Gi les et  a l  1982),
but  i t  can be argued that  the cut icu la b leeding r ime is
not  a resr  of  pr imary haemostasis .  This  may develop
rnto a circular argumenr in which those rypes of bleeding
time that can be shown to be in{luenced by clordng dis-
orders are bv def in i t ron deemed to measure secondary
haemostasrs
I f  thrombin does p lay a ro le in  pr imary haemosrasis ,
should a l l  b leeding r rmes be pro longed when the c lordng
mechanrsm is  d isrurbed? Ar f i rsr  s ighr  one is  tempred to
ans\\rer in the affirmative. If however primary plug forma-
tion u'as exrraordinaril-v sensitive to thrombin, so that only
traces of thrombin are required for its normal develop-
menr, then, paradoxically, rhis very high sensidviry would
lead to the same observations as in very low sensiriviry.
This is because rhrombin generarion so deficient as to nor
f  ie ld the necessary rhrombin mighr  not  be compar ib le
rvirh l ife. The exrreme sensirirnry of platelets to thrombin
cannot  be doubred (see p.  ooo) .  L i fe-compat ib le coagula-
t ion d isorders and ant i thrombot ic  t reatment  never  induce
zero rhrombin generation. Clirucal observarions on clorring
facror deficiencies and bleeding rime rherefore cannot be
expected to solve rhe issue conclus ively .
Different aherarions of rhe clorrrng s]'srem are reported
to affecr the bleeciing time. A series of different hepanns
caused pro longar ion of  the b leedrng r ime rn the rabbi r  thar
was srrongly l inked ro the rhromo:n inhib i r ion observed
(Palm et  a l  1990).  The ofren observed smal l  local  haemor-
rhage at  the s i te  of  a subcuraneous hepar in in jecr ion a lso
indicates thar  a h igh iocal  concenrrar ion of  hepar in under
cer ta in condi t ions mav imoair  haemostasis  in  a smal l
superf ic ia l  wound,
Ant ibodies thar  inh ib i r  rhe cara lvr ic  cenrre of  rhrombin
induce a severe haemorrhagrc s1'ndrome (Scully et al
1982,  Sie et  a l  199l ) ,  rvhereas an auroanr ibody d i rected
against a seconciary binding sire rhar impaired inreracrion
with fibrinogen, thrombomodulin and HC II, was even
accompanied b1' a thrombotic rendenc-v (Cosra er al
1992).  Hi rudin,  another  thrombin-speci f ic  drug mer
cause pro longed b leeci ing r imes u 'hen q iven in h igh doses
(Kaiser  & Mark,r 'ardr  1986,  Mark ' ,vardr  et  a l  1988,  I {ark i
&  Wa l l i s  1990 ) .
From these data i t  seems appropr iare ro conclude thar
thrombin p la-vs a ro ie in  the ear ly  react ions of  haemosrasis .
Observat ions on rhe (pr imary)  b leeding t ime do not
preclude,  but  on the conrrary are rarher  suggesr ive of ,  a
ro le of  thrombin in  pnmary haemosrasis .
Thrombin and haemostatic plug formation
A ser ies of  morphological  observar ions on rhe formar ion
of  the haemostat ic  p lug g ives a fa i r lv  dera i led p icrure of
t h i s  p rocess  and  a l l o r vs  an  assessmenr  o f rhe  poss ib le  ro le
o f  t h romb in  (Hov rg  e t  a l  i 967 ,  \ \ l es re r  e r  a l  1979 ,  Gr les  e r
a l  1982,  Sr-xma & r 'an den Berg 198,1,  \ rander Veiden &
Gi les 1988,  Hong vu Ni  & Gi les 1992).
The f i rs t  phase of  the haemosrarrc react ion is  rhe
adhesion of  p lare iers to col lagen and orher  componenrs of
the subendothela l  exrracel lu lar  marr ix ,  fo l iowed b-v rhei r
spreading on the sur face.  This reacr ion is  rhrombin inde-
pendent .  Plate iers adher ing to col lagen wi l l  encounter  rhe
f i rs t  t races of  thrombin,  mavbe drrecr lv  f rom rhe per i -
vascular  t issue.  Col lagen and rhrombin are the pr imar l ' ,
exogenous p lare ler  acuvators,  that  together  make p late lers
produce secondaq'  p late ler  acr ivarors Col lagen and
thrombin are a lso the onl l '  agenrs rhat  induce rhe ' f l ip-
f lop '  react ion and shedding of  microvesic les in  the p lare ler
membrane,  which provide procoagulanr  phosphol ip ids
and in this way fosrer thrombin formatron. (For a revierl
see  Sh ro i t  &  Zwaa l  1991 . )
A mass of  p late iets  accumulates on the adherenr  p lare-
lets ,  b1 '  p late let -p late let  in teracr ion and thus p lugs rhe
bleeding vessel .  P iasma is  t rapped in rhe inrersr ices of  the
plate let  mass.  The abundant  amounts of  procoagulanr
phosphoi ip ids and the facror  \ r  re leased bv the p lare lers
produce the condir ions ideal ly '  su i ted for  masslve
thrombin generanon.  For  p lare ler  cohesion,  i r  is  requi red
rhar  f ihnnosen is  nresenl  end thr t  the f ibr inooen rp.pnrnr
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forms bv a combinatron of  rhe g lycoproterns I Ib  and I I la
(GP I Ib- l I Ia) .  The receptor  forms revers ib ly  when p lare-
iets  are acr ivated b1 '  secondary act ivators but  i r revers ib ly
rvhen they are activated b-v thrombin (van Vil l igen er al
1 9 9  l ) .
In  rhe p iate let  mass,  no f ibnn is  obsen'ed,  but  morpho-
logical  changes occur  that  are dependent  upon thrombin
format ion and that  are absenr in  the case of  haemophi l ia
and much retarded in a case of factor MI deficiency
flr 'anderVelden & Grles 1988). These changes are inter-
digirarion of the plarelers, decrease of rhe intermembrane
distances and widening of the surface connected tubular
system. Only plareiet plugs in which rhese phenomena
are observed are stable. They are not seen in piugs in
haemophil ic dogs, but upon infusion of factor Xa and
procoagulant  phosphol ip ids rhese processes become nor-
mal (Hong 1'u Ni & Giles 1992). Around rhe primarv
plug, f ibrin strands are observed almost immediately
(Ves te r  e t  a l  1979 ) . I n  rhe  absence  o f  adequa te  t h romb in
generat ion the pnmary p lug rs  unstable.  These resul ts  in-
d icate that  rhrombin is  necessary for  adequate pr imary
piug formar ion b1 '  a mechanism independenr of  rhe
formar ion of  v is ib le f ibr in
Fibrous t ransformat ion is  rhe last  phase of  p lug devel -
opment .  The f ibr in  c lor  ar  rhe outs ide of  the aggregares
extends inu 'ards and gradual ly  replaces rhe p late let  mass.
Fibr in  threads that  connecr  coherenr  p lare ler  masses re-
t r rcr  and serum rs expel led This process obviousl -v  is  a lso
r h r n m h i n  r { p n e n r { p n t
v !  t / !  r r u L a r  L
From rhese observarrons i t  fo l iorvs that  rhrombin
pl r t 's  an importanr  ro le in  rhe formar ion of  rhe pr imary
h . - - . . . r ^ r ; ^  ^ t , , -r r u l r l r \ r J L o L r L  f , t u ;
Thrombin and platelets
Recenr,  exrremelv e leganr work by Vu er  a l  (1991) has
resolved the mechantsm of rhrombin acrivarion of plarelers.
Thrombin splits off rhe N-terminal portion of a rrans-
membrane molecule ( ' terhered- l igand acr ivar ion ' ) .  The
ne',r ' N-terminal rhan acrs as a i igand to the remainder of
thrs prorein recepror, r. l 'hich induces rhe acrivarion signal.
One of  the react ions provoked is  the membrane ' f l ip- f lop ' .
in  p late lets ,  l ike in  a l l  orher  cel ls ,  rhe procoagulant
phosphol ip id phosphat id l ' l  ser ine (PS) is  a lmost  enr i re ly
iocated at  the ins ide of  the p lasma membrane.  Thar is  why
intact cells are not procoagulanr whereas broken, lysed or
otheru ' ise damaged cel ls  are.  The p lare iet  is  rhe excepr ion
in that thrombin and collagen wil l induce a transbilayer
movement of  PS rn the p late let  so as ro make the extenor
of the intacr activared plareler procoagulant (Bevers et al
1932).  Ar  normal  p late ler  concenrrauons in the p lasma,
th is  rnechanism c ln be provoked b1 '  thrombin a lone
and col lagen has no addir ive ef fecr  (Beguin er  a l  1989).
Plate lets  thar  are loaded u ' i rh  the Fura-2,  so rhar  the inrra-
ce l l u i e r  Ca? ' concen r ra r l on  and  hence  ea r l v  ac t i va t i on
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F ig .  20 ,1  Ac t iva t ion  o f  p ro th r t rmb in  and p la te  l c ts  I ' l a rc lc rs  (2  x  l ( )8 /
ml )  loaded * rLh  the  Ca2 ' - ind ica t ( ) r ,  Fura-2 ,  wcrc  incubatcd  a t  37 'C
with factor Va (4{X) pM) and fact()r Xe (8 p,\l) At zcr(Fr.inrc
pr()thrombin (5OO tr.\{ f inal conccntration) was addctl ' I lrc incrcase in
cv toso l i c  Ca2 ' (dashed l ine)  was mon i lo rud  hv  ra t io  ( luor in tc tn '
( [ Ieemskerk  e t  a l  1992a)  A t  onc  mrnutc  ln tcn ' r l s ,  thc  t l r r r rml r rn
c o n c c n t r a L i o n  w a s  m c a s u r c d  h y  s u b s a m p l r n g  l n t ( )  a  s ( ) l u t i ( ) n  t r l  S  2 2 3 f i
t ' c r rn r rnu t lus  l inc )
can be moni tored,  show act ivat ion rvhen 0.1-0.2 n, \1
of  thrombin is  generated rn the medium (Fig.  20.1)
(Heemskerk et  a l  1992b).  This  represenls an extremel ] ,
low thrombin concenuat ion,  i f  one considers that  p lasma
conta ins :2 lLM prothrombin,  and that  the concenrrat ion
of  rhrombin reached in c lor t ing p lasma readi l l '  a t ta ins
peaks of  200 n lv{  (Beguin et  a l  1988).
Thrombin and the endothelium
Endothel ia l  ce l ls  prevent  thrombosis b1 '  borh thrombrn-
independenr and thrombin-dependent  mechanisrns:
1.  Synthesiz ing and re leasing the p late let  inh ib i tor
prostac.vclin (PGIr) and nruic oxide (,\ ' l ,oncada er el
L976). This function is stimulared bv thrombin ',r 'hich
mal '  be another  example of  a negar ive feedback acdon on
thrombin format ion bv in tacr  endorhel ium
2. Prouding thrombomodul in  that  b inds thrombin
lr' lrh high affrnrry and makes it loose irs procoagulanr
propert ies whi le  r t  acqui res the properq '  to  act ivate pro-
te in C (Comp eI  a l  1982,  Owen 1982).
3. Binding ancirhrombin III (AT III) via a proteoglycan
of  rhe endothel ia l  p lasma membrane and thus enhancing
its acdvrw so that it can more efficienrlv inacrivate
thrombrn (Hat ton et  a l  1978,  Busch & Owen 1982,
Colburn & Buonassiss i  I982,  Bauer et  a l  1983,  Marcum
et  a l  1984 ,  Ha l t on  &  Moar  1985 ,  Sh imada  &  Ozawa
1 9 8 5 ) .
4.  In i t rat rng the acr ive in ternal izar ion of  thrombin
(Lo l l a r  e t  a l  1980a ,b ,  Sav ion  e r  a l  1981 ,  Ca r l son  1986 ) .
5. Maintaining an asymmerry of the membrane that
prevents procoagulant  phosphol ip id species appear ing at
the luminal  s ide of  rhe cel l  (Shroi r  & Zwaal  l99 l ) .
Thrombin a lso may induce shape changes in endo-
thel ium, u 'h ich exposes subendorhel ia l  marr ix  wi th t rssue
factor  acr ivr t l '  f lVeiss et  a l  1989).  However,  i t  is  ques-
troned rvherher this phenomenon occurs in vivo (fhomas
& I{erton 1982).
Extravascular thrombin?
The proenz,vmes and inhibitors of the coagulation
mechanism have a M. less than 70 000, so they wil l prob-
ably occur in the extracellular f luid. The cofactors V and
VIII have a M, greater than 300 000 and wil l not normally
occur extravasculary. Because tissue thromboplastin is
present extravasculary on cells around the vessels flWeiss
et al 1989) the condinons wil l allow a slow generation
of thrombin extravasculary. Because of the presence of
inhibitors, this wil l ranslate into a steady state of low
rhrombin concentrarion. Extravascular thrombin to our
knorvledge has never been directl l '  demonstrated in
heal thv t issues.  F ibr in  deposi ts  in  in f lammat ion and other
conditions demonsrrare rhat, under pathologrcal circum-
stances,  thrombin must  occur  commonly in  the extra-
vascular  space.  I f  i t  ex is ts  in  normal  t issues then a
number of  common enigmas wi l l  d isappear;  especia l ly
rvhere positive feedback mechanisms require the presence
oi minute amounrs of thrombin before rhe system can
produce more.
Non-haemostatic activit ies of thrombin
A'l,anv acrions of thrombin have been reported that are not
i rnmediare l ' r '  e lated ro the haemostat ic  process,  a l though
soner imes one can imapJrne a ro le rn t issue repai r .  Cel l
proiiferation activiry has been described for f ibroblasrs,
spienocvies and endothel ia l  t issue (Chen & Buchanan
1975,  Teng & Chen 1975,  Pohianpleto 1977,  Zeter  et  a l
1977 ,  Bake r  e t  a l  1979 ) .  O rhe r  ac t i ons  a re  chemotac t i c
acuviry (see p. .oo), srimularion of nerve cells (Sinder et
a l  I984) ;  contract ion of  smooth muscle t issue ( lValz et  a l
1985);  in i r ia t ion of  bone resorpt ion (Gustafson & Lerner
1933) and enhancemenr of  v i ra l  in fect ivr ry  (Dubovi  et  a l
r  9s3)
Thrombin interacrs r+'ith almost all cells via membrane
receptors (Shuman 1986). This inreraction may be
enzl'maric, as in rhe case of the plateler receptor described
b r ' \ / u  e t  a l  ( 1991 ) ,  bu t  i n  o rhe r  cases ,  such  as  when
rnactivared thrombin also produces the effect, one may
guess thar nonenzymaric binding of thrombin ro the
receptor  causes rhe response.
The chemoracric acrivitf is nonenz,rrnatic and resides
in a unique protein domain (prorhrombin 338-400), pos-
sibli '  rnvolving the anionic binding site of thrombin
(Ba r -Shav i r  e t  a l .  1983 ,  1984 ,  1985 ) .
cr-Thrombin srimulates fibroblast receptors by rwo
mechanisms; a nonen4'matic one mediared by a-thrombin,
acrive or inacrive, bur nor by y-thrornbin and a presum-
abiv enzvmatrc one, rn which cr- and 'y-thrombin act, but








rnacr ivated thrombin does nor .  Both mechanlsms are nec-
essary for  inducing mi togenesis (Carney et  a l  1984,  1986),
Some of  the actrons of  thrombin on cel ls  may be v ia
splitt ing of f ibronectin or laminin (Goldfarb & Liotta
1986,  Mosher & Thompson 1986),  possib ly  act ing a lso
on laminin incorporated in a clot (Bale et al 1985).
Thrombin binds covalently ro platelet thrombospondin
f feo & Derwi ler  1985).
Thrombin increases the permeabil iry of the endotheiial
celi ipyer by inducing a shape change that leads ro the
forn:adon of gaps (Malik er al 1986). It also increases
neutrophil adherence via an endothelial cell-dependent
mechanism (Zimmerman er al 1986).
Thrombin-elicited aortic contractions are dependent
upon a catalytically active enzyme and are evoked by
phvsiologcally relevant concenuadons; 200 nM thrombin,
a normal  va lue at ta ined local l ,v  in  c lotdng p lasma, is  a
sublethal  dose when inyected and causes maximal  contrac-
uon of  aona smooth muscle cel ls  (Va)z er  a l  1985).  Con-
t ract ion is  nor  dependent  upon endothel ium, but  is
probablv dependent  upon Ca2'  mobi i rzat ion.  Inact ive en-
zvmes do not interfere with the acuon of actrve thrombin,
y- thrombin is  as act ive as cr- thrombin.  (See a lso:  \Y/h i te et
a l 1 9 7 5 , 1 9 8 0 ,  1 9 8 4 ,  H a v e r  &  N a m m  1 9 8 3 ,  1 9 8 4 . )
THE FORTVI.ATION AND INACTIVATION OF
THROMBIN IN PIASAIA
The core of the mechanism
The marn chain of  t issue thromboplast in- induced proteo-
Ivtic acrivations in 't",",:,:r '  
. _. ry lV I I I = X = I I r
For  inr r ins ic  coagular ion the main chain of  acr ivar ion is :
P K + X I I = X I = I X = X + I I
A1l the non-activated clorting factors participaring in these
chains are proenzyrnes of  senne proteases,  the acnvated
enzlmes consequently are serine proteases. Clorting fac-
tor activation is an extremely slorv process unless a suit-
able interface and specific protein cofactors are present. A
complex of  FXa,  FV,  Caz'  and phosphol ip id is  necessary
to acquire the normai  reacr ion veloc in '  (Papahadjopoulos
& Hanahan 1964,  Hemker et  a l  1967).  The actrvat ion of
prothrombin by factor Xa in free solution is at only
0.001'Z '  o f  the normal  speed (Esmon et  a l  1974a,b,
Douning et  a 1975).  Phosphol ip ids d imin ish the K, , ,  for
prothrombin conversion abour a hundred times, which
means that the enzyme can be saturated i\ ' i th substrate
2 l n  t h r s  a n d  s u h s e q u c n t  r e a c t i o n  s c h c m c s ,  t l l c  d n ( r \ r ' ( = )  r c p r c s r n t s
pro teo lv r ic  ac t i va t ion  and no t  chcmica l  convcrs ton  Squarc  b rackcrs
( [  ] )  ind ica te  enzymat ica l l y  ac t i ve  complcx<s  [ 'K  =  p rcka l l i k rc rn ,  
' l -1 .  
=
t i ssue fac to r ,  p [ -  =  phospho l ip id  Romun numcra ls  ind icu tc  thc  luc to rs
I I  =  Fro thrombin ,  c tc
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at rhe nornral plasma concentration of prothrombrn
(- 2 pM), rvhereas factor Va increases the tumover
number (ft.,,) about 1000-fold, i.e. the number of thrombn
molecules produced by the enzyme at saruration with the
substrare increases a 1000-fold CI., lesheim et al 1979,
Rosing er al 1979, 1980, Lindhout er al 1982, van Riin et
a l  1 9 8 4 ) .
The factor X activating enzyme consists of factors \IIII
a and IXa and phospholipid, forming a complex com-
pletel.v analogous to the prorfuombinase complex ftIemker
& Kahn 1967,  van Dieyen et  a l  1981,  1985).  Apart  f rom
rheir kinedc effecr on k.",, the factors Va and VIIIa also
serye to improve the binding of their respective enzymes
(FXa and FIXa) ro phospholipid (Vande Vaart et al
1983 ,  van  D ieyen  1985 ) .
Factor VII and tissue thrombopiasdn form a complex
that is again comparable to prorhrombinase flesry &
Nemerson  1974 ,  S i l ve rbe rg  e t  a l  1977 ,Zv  &  Nemerson
1980 ,  Nemerson  1983 ) .
\ \ /e  can summanze the react ions of  the c lass ical  coagu-
lat ion pathu,avs as fo l lorvs:
Exrr ins ic  pathwal ' :
[VII, TF, PL] = [X, Va, PL] + II
lnrnnsic  pathway:
PK = XII = XI = [X, VIIIa, PL] + [X, Va, PL] = II
The imporrance of the role of the contact activating
svstem in normal  haemostasis  has not  been unequivocal ly
demonsrrated.  As Iong as coagulat ion is  d iscussed in
terms of the tvvo merging pathways depicted above, the
contact- t r iggered int r ins lc  pathway is  the only possib le
\\,ay to account for a role of the antihaemophil ic factors
VIII and IX. Since it has been shown, however, that factor
VII can activate factor IX, the role of the anrihaemophil ic
factors in thromboplastin triggered coagulation became
apparent f losso & Prou-\Xtartelle 1965, @sterud & Rapaport
1977,  Mar lar  & Gr i f f in  1981,  Ma )( r  et  a l  1989).  This
means that factor X can be activated either direcrly by
factor VII and tissue thromboplasrin or indirectly by
factor lXa (togerher wirh facror VIIIa) that in its turn has
been acr ivared b} '  fss1. .  VI I .  I t  is  easy to see that  the
function of this pathway urll sti l l  be dependent upon the
amount of thromboplasrin available. The contriburion of
rhe direct, one-step acnon of factor VIIa on factor Xa
formation wil l be roughl-v propordonal to the concentra-
t ion of  rhromboplasdn but  l imi ted in  r ime because of
the effect of the tissue factor pathway inhibitor C|FPI)
( p . . o ) .
The conrr ibur ion v ia rhe oarhwav:
\rII + IX +X
u' i l l  be sub)ect  to  the same inhib i t ion,  but  the resul t  wi l l
be thar a definite amounr of factor X acrivator remains
availabie in rhe form of factor IXa and its cofactors.
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\(zith the recogrirron of this loop, the earlier conrra-
dicdon benryeen the clinical importance of rhe anri-
haemophil l ic factors ftrIII and IX) and the relative lack of
importance of the contact factors disappears. This means
that rissue factor becomes the only imporranr trigger of
coaguiadon, as long as no foreign surfaces play a role.
The fact that factor XI deficiency can glve rise to seri-
ous bieeding, although it may equally weli pass unnoriced,
can however not be readily explained by rhis reaction
scheme. Two possible solurions present rhemselves: in rhe
firsr place factor XI is a substrate for facror XIIa. The
latter factor also triggers components of the fibrinoiyric
system. Factor XI, as a subsEare, is necessarily a com-
petidve inhibitor of rhe frbrinolytic activarion. This might
cause haemorrhage by hyperhbrinolysis. The facr rhat rhe
rype of haemorrhage seen in factor XI deficiency ofren
shows the clinical characreristics of hyperfibrinolvric
b leeding (Sei igsohn 1992) suggests th is  mechanism. A
second possibil iry is thar factor XI m11' be activared b1'
thrombin (Gailani l99l) and thus ma1' form parr o[ a
hi ther to unrecognised feedback loop.  Cl in ica l  observa-
dons suggest strongly that bleeding in facror Xl-deficienr
padents is (also) derermined bv unidentif ied facrors
different from the factor XI level (Raeni et al 1985)
Feedback activarion of thrombin formation
I t  is  essenr ia l  for  the correct  funct ion of  rhe haemostar ic
mechanism that  thrombin formar ion be precisely  con-
t ro l led.  The st rong f lou '  a t  the s i te  of  a wound,  generated
by the b lood pressure,  means that  thrombin that  was
formed s lowly,  even in massive quant i t les,  would be
washed away.  This u ' i l l  not  be the case i f  thrombin for-
mation occurs explosively after a given lag dme. The
srrongly nonlinear generation kinetics of thrombin forma-
t ron is  caused by feedback act ivatron,  r .e .  act ivat ion of
thrombin format ion b1 '  thrombin i tse l f  This  mechanism
as such was recognised more than 40 years ago OVare &
Seegers 1948,  Alexander et  a l  I950,  Brggs & Macfar lane
1953). Yet its importance for the understanding of rhe
krnetics of thrombin generation and the influence of and-
coagulant drugs seems to have been somewhrt neglecred
Recent studies on the mechanism of action of heparins
have st ressed i ts  importance (Ofosu er  a l  1985,  Hemker
1987 ,  Begu in  1988 ,  1989 ) .
Both factor VIII and factor V have to be activared
before they can pla-v their role as protern cofactors to the
clottrng enz_wnes (Rapaporr er al 1963). Akhough facror
Xa is an efircient acrivaror of facror Va (Monkovirz &
Tracy 1990) and of  facror  VI I I ,  in  p lasma thrombin seems
to be the only enryme rhat brings about these acrivations
(Pieters er  a l  1989).  Under rhe in f luence of  rhrombin,
p late iets  wi l l  shed factor  V,  which subsequenr ly  is  acd-
vated by the same rhrombin,  I r  has been shown rhat  rh is
acrivarion rather than the release reacrion irself is rhe
rate-limiting factor for the generation of factor V activiry
f rom act ivated p iate lets  (Baruch et  a l  1986).
A second procoagulant function ofplatelets, induced by
thrombin as rvell as by collagen, is the platelet 'f l ip-flop'
reaction (Shroit & Z'*'aal 199 l). At the piatelet concen-
rrarion of normal platelet-rich plasma, thrombin alone is
capable of inducing the fl ip-flop reaction, and platelet-
mediared phospholipid availabii iry is an important, rate-
l imirrng, feedback process in thrombin generadon.
The feedback activation of factor VII by its products,
facror Xa, and factor D(a is discussed below as part of the
starting mechanism of coagularion (p. ooo;.
Feedback inactivation of thrombin forrnation
Ir is equally essential that borh the explosive formation of
rhrombin occurs and that it is i imited ro the site of the
tr igger ,  ie .  to  rhe s i te  of  damage.  Otherwise general ized
thrombosis rvould be the logical consequence of the
smallesr u'ound. The limitatron of the explosion is due to
inhib idon of  the acr i ! 'e  complexes.  This inhib iuon is
sometrmes triggered bv the activated products (factor Xa
and rhrombin)  Thrs means that  besides feedback act iva-
r ron,  ieedback inhibr t ion a lso p lays an important  ro le in
the coagularion mechanism. There are rwo lmportant
mechanisms thar depend on the previous activation of a
c lot r ing factor  and rhat  lead to eventual  inh ib i r ion of
thrombin formar ion.  These are :
l. Prorern C- and S-dependent inactivadon of facrors Va
and \TI Ia
2 The tissue factor pathu'af inhibitor mechanism (ussue
factor pathrvaf inhibrtor CI-FPI) = extrinsic psthway
rnhibrtor (EPI) = hpoprotern-associared coagulanon
inhibitor (LACI))
Downstream of a srre of damage in the vessel wall there
will be a reglon with intact endotheliurn. Thrombin binds
rvith high affiniry to thrombomodulin and undergoes a
modularion of irs specificit l ' .  It is no longer capable of an-v
acrion on the cloning factors I, V, VIl l, or XIII. Instead it
becomes capable of activating protein C. Protein C is a
vitamin K-dependent pre-serine protease that, once it is
acdvated by the thrombin-thrombomodulin complex,
becomes a potent inactivator of factors Va and VIIIa. This
means rhar rhe sun'ival t ime of any prothrombinase and
tenase actlon rn a region l ined by intact endothelium
musr be verl '  short. The action of acdvated protein C is
markedly enhanced b1' another vitamin K-dependent
facror ,  prote in S.
The trssue factor parhwaf inhibitor was recognised as
eariv as 1952 (Hlort 1952), and rediscovered in the late
I980s (Rao & Rapaport  1987,  Sandset  et  a l  1987,  Broze
et  a l  I9 .88,  for  a rev ie"v see Sandset  &Abi ldgaard l99l ) .  I r
rs  a c i rcu lat ing p lasma prote in rhat  is  a lso adsorbed on the
endorhelial rvall but can be released under the influence of
hepar in (Sandser et  a l  1988).  I r  has rhe capaci ry  ro b ind ro
acnvated factor X and form a compiex thar is a srroirg
inhib i tor  of  the thromboplasr in- iacror  VI Ia complex.  This
mechanism ensures that t issue factor-induced facror X
acuvation wil l stop as soon as a sufficient amounr of factor
X" has been produced.
Platelets and thrombin formation
Platelets contribute to thrombin formation in four rvavs:
L By the flip-flop reacrion
2. By sheddrng phospholipid-nch mrcropardcles
3. By releasing factor V
4. By crearing a zone of zero flow withrn the plareler
aggregate.
The fl ip-flop reaction is discussed in more detail above
(see p.  ooo) .  The micropart ic les ( 'p late ler  dusr ' )  are smal l
parrs of  the p lasma membrane,  p inchEd of f  dur ing shape-
change and f l ip- f lop (Sandberg et  a l  1982,  Shroi t  &Zwaal
1991).  When thrombin generat ion is  fo l lowed in p lare ler-
r ich p lasma, a c lor  forms in the ear l l '  phase of  explos ive
thrombin format ion.  I f  th is  c lor  is  removed,  and wirh i t
the p late lets ,  thrombin generat lon cont inues undisrurbed,
indicadng that  the phosphol ip id shed f rom rhe p lare lers
can support  normal  thrombin generat ion (Beguin et  a l
l  98e ) .
The concentat ion of  factor  V in  p late ler-poor  p lasma
is abour 25 nM whereas that  of  i ts  par tner ,  facror  X is
around 200 nM. This mar '  lead one to rh ink rhar  the
contr ibudon of  p late let  facror  \ /  mav be importanr  in  v ivo.
The aggregat ion of  p late lets  at  s i tes rvhere the haemosrar ic
mechanism is  act ive u ' i l l  cause a fur ther  increase in rhe
rat io  of  p late let - factor  V to p lasma-factor  V (see ear l ier ) .
Factor  V is  re leased f rom plare lers rn i rs  non acr ivated
form and the conversion into facror Va is rare-limitrng for
i ts  acdvi ry .  In  p lasma, facror  V is  present  in  a concenrra-
t ion ( -  25 nM) that  is  much lou 'er  rhan rhat  of  r rs
par tner  facror  X ( -  180 nN{)  The p iare lers f rom normal
p lasma-r ich p lasma wi l l ,  upon complere re lease,  double
the plasma concentration of factor \/. In a platelet aggre-
gate the increase'* ' i l l  be st i l l  more imporranr .
It is often not recognised that rhrombin formadon in
vivo u'i l l  hardly ever occur in plasma as such, bur alwal's
in or near plateier aggregares. The natural mil ieu for
thrombin generation is probably rhe crevices rvithin a
platelet aggregate and in the rissue around a damaged
vessel .  In  the b loodsteam, outs ide rhe aggregare,  unless
the b lood is  sragnant ,  f low'" r ' i l l  qu ick l l 'd i iure any acdvated
clorr ing facror .  I f  we rake normal  c i rcu lat ion r ime to be 40
seconds and i f  we assume complere mix ing of  rhe b lood
dunng th is  t ime,  than i t  is  c lear  rhar  any Iocal  process has
ei ther  to be extremely quick,  as p lare ler  acr ivar ion is
but  thrombin format ion is  nor ,  or  has ro be local ized by
stagnat ion of  the f low.  In normal  haemosrasis  and arrer ia l
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thrornbosis the crevices of the aggregate are suitable can-
didates for the crearion of microscopic stagnanr pools.
Stagnant  pools of  b lood in a wound or  in  the venous
crrcular ion are obvious orher  oossib i l ides.
The starting mechanism, partial coagulation
mechanisrns
The current vie"vs on the stardng mechanism of coagula-
tion, i.e. factor VII-rissue factor interaction, differ. One
school holds that the proenzyme factor VII has a non-
negligibie enzymatic acriviry Gujikawa et al 1974, Kisiel
& Davie 1975, Nemerson 1983). Once factor VII(a)
adsorbs onto dssue thromboplasdn, its activiry is en-
hanced so as to become sufhciently imponant ro start the
clottrng process. An alternative view is rhat the activarion
of facror VIi to its two-chain form is essendal for its acdv-
i11'. This form can be generated from the one-chain form
in a number of different ways, such as by activated factors
X or  IX (Radcl i f fe  & Nemerson 1975,1976,  Sel igsohn et
a l  1979 ,  l \ { asvs  e t  a l  1982 ,  Rao  e r  a l  1985 ,  1986 ) .  I t  i s
importanr  to note that  here again a feedback mechanism
is operative: The products of factor Vll(a)-tissue factor
interaction, i e. factors Xa and IXa, activate factor VII.
The contact activation mechanism can aiso enhance
facror \rII acrivin' in virro (Akman & Hemker 1967); the
cold activation of factor VII, involving kall ikrein and
di f ferent  other  prore ins,  a lso has been wel l  establ ished
(Gjonnaes er  a l  1972,  Gjonnaes 1973,  l :ake et  a l  1973,
l -aake & Elhngsen I97.1,  Czendl ik  et  a l  1985,  Mul ier  et  a l
i 9 8 6 )
- he full coaguladon mechanism discussed so far cannot
be operr t rve f rom t ime zero because b lood,  immediate ly
after the coagularion reaction has been triggered, does
nor conrain facror Va, facror VIIIa and sufficient pro-
coagulant  phosphol ip ids.  These have f r rs t  to  be provided
bv thrombin-dependent  feedback react ions.  So in order
to srarr full-blon'n thrombin formarion, incomplete partial
mechanisms have to form small amounts of thrombin
hrst .
Vhen blood comes into contact with tissue thrombo-
plasrin (e.g. in rhe determination of the prothrombin
time (PT) and probably in all haemostatic and thrombotic
reactions in vivo), one can imagine factor VII (or factor
VIIa acrrvated in an, unti l now, unknown way) to acd-
vate some factor X. The factor Xa then, with the
phospholipids available, may form some thrombin from
prothrombin. These first molecules may start the feedback-
activated full mechanism that is discussed above. Vhen
blood is acuvated viA the contact activation system, as in
the activared parrial rhromboplastin dme (APTT), rhan
acuvared factor IX, without factor VIIIa, wil l have
ro activate some factor X. This factor Xa, without factor
Va rvil l  have to activate some Drothrornbin before the full
mechanism can star t .
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In order for the full mechanism of coagularion ro be
operative, rhrombin firsr has ro be formed by' a pardal
mechanism. \Ve therefore cannor speak of rhe mechanisrn
of blood coaguiation. In facr there musr be a series of
subsequenr mechanisms. This is especially irnportanr ro
keep in mind when inrerprering the resulrs of PT and
APTT. These tests measure rhe lag rime of rhrombin
formadon. Therefore they are more l ikely to reflecr pardal
mechanisms rather than the full mechanism.
Thrombin, fibrinogen and fibrin
Thrombin converts frbrinogen ro fibrin (see Ch.2l).
Fibrin is not an inert lanice. Abour 40',/n of the rhrombin
generared in plasma is incorporared inro the generated
fibrin, where it is prorected from inhibitors (Liu er al
1979,  r$( / i lner  et  a l  I981,  Francis  er  a l  1983) F ibr in  rhus
plays an importanr role in limidng the-activiry of rhrombin.
Parienrs wirh a congenitally abnormal f ibrinogen rhar does
not  b ind thrombin,  show a rhrombor ic  tendencv.  F ibr in-
bound thrombin retains its enzvmatrc acrivirv and cannor
be inacdvated by (heparin-) AT IIL During fibrinoll 'sis ir
is  re ieased and mav cause rethrombosis.  Facror  XI I Ia
arises from irs plasma proenzyme (facror XIII) b-v rhe
acdon of  thrombin (Lorand 1986).  In  p lasma, factor  XI I I
is  bound to f ibr inogen.  I t  is  acr ivated by thrombin,  bur
only in the presence of f ibnn srrands, i.e when rrs
substrate is  a l ready presenr.
Radio label led cata lvr ica l lv  inacr ivared cr- - rhrombin in-
corporates into forming clots l ike acrive rhrombin, u'hereas
1-thrombin and the hirudin complex do not (lVilner er al
l98 l ) .  This  occurs v ia an anionic  b inding reglon (Ber l iner
et  a l  1985).  This  same region appears to be rmporranr  for
the b indrng of  thrombin ro cerra in cel l  receprors (Carney
er a l  1984).  Act ivared neutrophi ls  re lease e lasrase rhar  can
degrade clots and set free a-rhrombin. Elasrase also con-
verts u,-thrombin into a y-thrombin-like form rhat has no
cloning activlry, but may rerain other biologrcal acrivrries
(Brower et  a l  1986).
Forms of thrornbin
In addition ro cr-rhrombin, rhe form of thrombin rhar is
the immediate end producr of prorhrombin acrivation,
rwo furrher thrombin producrs can be idenrif ied, [ i-and 1-
thrombin. These are degraded forms that mav arise from
autodigesdon of a rhrombin prepararion. No physiologr-
cal functions have been claimed for these degradarion
producrs.
Meizothrombin is a molecule wirh rhrombin activity
that arises when only one bond is splir in prothrombin
instead of  rwo (see Ch.  I8) .  Meizothrombrn conralns a
funcrional active cenue but also the N-terminal fragments
I and 2, i.e. the domain wirh rhe carboxylared gluramic
acro res idues.  I t  is  quesr ionable wherher  meizothrombin
arises dunng rhe clorrrng of normal plasma (fans et al
l99 l  ) .  I r  has been postu lared horvever  thar  meizo-
thrombin can form ar rhe endorhelial surface and play a
role rhere in rhe negarive feedback reacrions mediated by
thrombin ( f i jburg er  a l  l99 l ) .
Inactivation of thrombin
In plasma, thrombin and factor Xa are quickly inacrivared
by a number of anriproreases. Anrithrombin III is rhe
main one, contributing 64"/o to the total antithrombin
acdvrry. cr"-Macroglobulin is the nexr mosr imponant
antithrombin, conrriburing 23"h, and the remaining
anriproteases, primarily crr-anrirrypsin, are responsible
for the remaining Ll"/u of anrithrombin acriviry (Hemker
et al 1986). Heparin cofacror II has no acriviry unless
acovated,  e.g.  by dermaran sulphare.  The hal f  l i fe  of
thrombin in  p iasma is  14 seconds ar  an AT I I I  concen-
tration of 2 pA{. The corresponding half l i fe of factor Xa
is 32 seconds.  Acr ive hepar in wi th a chain length of  l8
monosacchar ide uni rs  or  h igher  increases rhe act ivr ty  of
AT III both towards thrombin and rorvards facror Xa
several  1000-fo ld.  In  p lasma, rhe rare of  inact ivat ion of
thrombin and factor  Xa is  proporr ional  to  borh rhe AT I I I
and rhe hepar in concentrar ion (B6guin er  a l  1992).  The
rat lo  of  the inact ivat ions remains a lways the same, i .e .
thrombin is always inacrivared about rhree times as fasr
as factor  Xa,  independent  of  the presence of  hepar in.
Acnve heparins with a chain length of beru'een hve and l7
monosacchar ide uni rs  are inact ive rowards rhrombin
inacl rvat ion bur  mainta in thei r  acr iv in '  towards factor  Xa
rnacr ivat ion Factor  IXa is  insensi r ive ro AT I I I  acdon
but not to the action of rhe AT ll l-heparin complex
(P ie te rs  e r  a l  1990 ) .
The effecr of AT III, and hence of heparin on rhe
appearance and d isappearance of  rhrombin in  c lorr ing
piasma is complex Enhancemenr of rhrombin inactiva-
rion has two effecrs. There is a direct and proporrional
effect on thrombin, which means that, when thrombin
disappears ru'ice as fast as normal because of the presence
of heparin, then the concentrations of thrombin seen in
clorting plasma are half normal. In addition there is an
rnhibit ion and rerardation of thrombin generation velociry
that rs due to rhe inhibirion of rhrombin-dependent feed-
back effecrs The exrenr of rhis inhibiricin is dependent
upon the experimental circumstances. It is much more
obvrous in the inrrinsic coagularion parhway than in the
extnnsic one This is why rhe APTT is much more
sensrnve ro heparin rhan is the prorhrombin rime (PT)
(Hernke r  1987 ,  Begu in  e r  a l  1988 ) .
Factor Xa is presenr in excess when plasma clots after
init ianon by eirher the extrinsic or the intrinsic parhway.
For the prothrombin converring acriri 'ry, factor Va is the
rare-limiung factor when enough procoagulanr phclspho-
l ip ids are presenr (PT and APTT).  Phosphol ip ids are
rate- l imir ing for  rhrombin generar ion in  p lare ler- r ich
plasma. V,?ren rhey are supplied, facror Va again becomes
rate l iminng (Beguin er  a l  1989).  Because of  rhe excess
of facror Xa, inhibiron of factor Xa is an inefftcienr
means of inhibidng thrombin generarion. However, factor
IXa inhibit ion conrribures significandy to the inhibirion
of inrrinsic thrombin generarion.
The complex of rhrombin and cr,-macroglobuiin has
no known acrivlry on any high molecular v,eight (i.e.
physiologically importanr) substrate. Ir mainrains acdvrry
againsr small molecular weight, chromogenic subsrrares.
This accounts for the considerable rhrombin-like
amidolytic activlry in serum.
THE ASSESSMENT OF THROA{BIN DIRECTED
ANTITHROMBOTIC ACTION
\Ve may conclude from the above that the enzvmatic
acr ion of  thrombin on a large number of  subsrrates is
essent ia l  in  haemosrasis  and thrombosis.  The amounr of
thrombin that  can express i rse l f  in  rhe process of  hae-
mosrasis  or  thrombosis wi l l  rherefore derermine rhe
magni tude of  the haemostat ic  and thrombodc response
,--Eudenrlf ir is nor imporrant horv rhe amounr of ,Shrombin
" . , .  
- . . '  is  decreased.  Normal  prorhrombin convers ion. ih ib i r ion
of  the thromb, lq formed (h i rudrn,  dermeran sulphaqg,
t  mosr  hepar ins j f f in t r iu i red-prorhrombin converstoni f ,b
normal  thrombin inact ivat ion (ora l  anl rcoagulr t ion,
pentasacchar ide)  u ' i l l  a l l  have rnt i rhrombot ic  and anrr-
haemosriric effects.
I t  would be usefu l  to  have a test  rhat  could be carr ied
our in  the p lasma of  a par ienr  and thar  n 'ould d i rect . iv
indicate the anr i rhrombor ic  ef fecr  obra ined bv rhrombrn
inhib i r ion.  Current  pract ice onlv provrdes indrrecr  meas-
ures that may or mav nor correlare u'irh rhe anrirhromboric
ef fect .  The prothrombin r ime corre lares * ' i th  rhe anr i -
rhrombor ic  ef fect  broughr abour b1 '  ora l  ant icoagular ion,
The APTT indicares rhe ef fect  of  hepar in.  Dermatan
sulphare or  penrasacchar ide wi l l  hard l f  in f luence e i rher
PT or APTT. The fact thar different drugs, at effecrive
concenuarions, have Iargely different influences on these
tesrs a l ready indicares rhar  nei rher  can be rhe unrversal
parameter that we look for. The reason for thrs is easy to
imagrne. Clorting invanabiy occurs rvhen a level of l0-
20 nM of  thrombin is  reached in b lood or  p lasma Thar is
shor t lv  af ter  the onset  of  rhe fu l l  coagular ion mechanism.
The c lotung t ime rherefore measures the iag-r ime o i
rhrombin formar ion durrng u 'h ich main ly  parr ia l  c lorr ing
mechanisms and thrombin mediated feedback are opera-
t ive.  Consequent ly  rhe in f luence of  a drug on a c lor t ing
t ime largely represenrs i rs  ef fect  on a parual ,  in i t ia t ing
mechanism and nor  on the fu l l  mechanisnr .  Yet  i r  is  rhe
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eifect of these drugs on rhe full mechanism of rhrombin
generat ion and inacr ivadon rhar  determines rhe and-
thrombot ic  ef fect .
A simpie clinical obsen'adon ii lusrates rhis poinr. A
parient with a congeniral AT III deficiency of 50'% will
have a thrombotic tendenry. Yer none of the possible
varianrs of rhe clorring time wil l show significanr prolon-
gation. Oral anricoagulation wil l bring the thrombosis
risk ro normal and ar the same time decrease the PT and
APTT values to pathologcally low ievels.
One endry rhar is changed in these padents is the
amount of thrombin formed. More precisely: the amount
of thrombin formed and rhe rime that ir has ro acr.
Thrombin is an enzl'rne, and in Ebieit a fair approxima-
tlon one can expecr that I nM of an enzyme acting for l0
seconds wil l have rhe same effecr as l0 nM acting for I
secondS.This means that  rhe producr  of  t ime and con-
centration determines the effect of thrombin. A normal
amount of thrombin rhar persisrs longer because of a con-
geni ta l  lack of  ant i thrombin I I I  may cause rhrombosis.  A
tendencv to thrombosis can be remedied by lowering rhe
amounr of thrombin formed via oral anticoagulation or by
makrng a normal  amounr of  rhrombin d isappear fasrer
than normal  v ia hepar in adminis t rauon (Fig.20.2) .  This
demonstrates that  the product  of  concentrar ion and t ime
rs an important  var iabie.  \Ve cal led th is  var iable the
thnt t t tbrr r  potct t t iu l  (77)  (Hemker et  a l  1989).  k  is  not  a
nc\ \ '  concept ,  the area under the thrombin generat ion
cun'e,  in t roduced over  40 vears ago (Biggs & Macfar lane
1953 )  r s  p rec i se l l ' r he  same th ing .  The  TP  has  the  d i -
mensron of  r ime mulr ip l ied by ( thrombin)  concenrrat ion
and r ts  value rn normal  p lasma, under rhe exper imenta l
c i rcumsrances of  Bdguin er  a l  (1988),  is  g iven in Table
20.1.  The values of  TP obrained rn p lasma may depend
upon the exper imenral  condi t ions,  such as inrr ins ic  or
exrrinsic clorring. Thel' vary onlv a i itt le wirh thrombo-
piast in  concentrat ion.  
, r  
' t '
i t  is  c la imed thar  rhere are anr i rhrombor ic  drugs,  l ike l '
c iermatan sulphate,  penrosan polvsulphare or  Iactobionic
aciJ ,  thar  'do not  in f luence coagulat ion ' .  In  our  exper i -
ence the-v have indeed iitt le influence on the APTT
but thev invariably bring abour a significanr decrease of
t he  TP .
The enzl'matic acrion of rhrombin means that the con-
cept of TP can be used in ] 'et another way. If we irnagrne a
biood plareler rhar is being triggered by thrombin, rhen
the rriggering wil l rake effect afrer a cerrain number of
specific recepror molecules at rhe piareler surface have
been spl i t .  Thrs can be broughr about  by a h igh concen-
tration of thrombin in a short t ime or by a lower concen-
I rat lon ln  a proporr ional lv  longer dme. Again the product
of rinie and concenrration counts. The same holds true
ior rhe clorting of f ibrinogen. Clotung u'i l l  occur when a
EJrven concentration of f ibrin monomers has been reached,
We developed a method to determine the Tp in a
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t  - l - l ' r c l l cc rs  the  t l r ronrh in  conccn( ra t i ( )n  and thc  t rme in  wh ich  i t  ac ts
i .e .  when a g iven amounr of  rhrombin has been acr ing
on the fibrinogen for a given rime (Hemker er ai lg79).
In this !r 'av one can speak of a rhreshold value of the
TP necessarv ro provoke a given phenomenon (fable
2 0 .  I  ) .
In these rerms one can rhink of thrombin-mediated
antithromboric medication as rhe adminisrrarion of a drug
so as ro decrease the TP value ro under the rhreshold l imi t
of  rhrombogenesis lvh i le  remain ing above the threshold
of  haemosrasis .  k remains an open quesr ion wherher  the
n3ture of  rhe drug has an in f luence on rhe thresholds.
Those who look for rhe ideal anricoagulanr, thar prevents
thrombosis lv i rhour  in f luencing haemostasis  tac i t ly  as-
sume rhar  rh is  is  possib le.  In  our  opln ion th is  is  not  very
hkell '  The differences ber$'een drugs are due ro rheir
dr f ierent  phrrmacokiner ic  properr ies,  \ \ 'h ich af fect  rhe ease
\ \ ' l th  \ \ 'h ich rhey can be mainra ined in rhe requi red range
of  p lasma ievels (e g lou '  molecular  weighr  hepar ins
\ rersus unfracr ionared heparrn) .  A lso secondary c i rcum-
stances mav inter i 'ene Drugs that  act  vra hepar in cofactor
I I  (dermaran sulphare,  iactobionic  ac ld)  can hardly  be
overdosed because rhe p lasma level  of  hepann cofacror  I I
is  ior i 'er  thrn thar  of  prorhrombin,  so thar  rhe Tp cannor
be  i nh ib i red  bevond  a  ce r ra in  l eve l .
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b ind ing  and enzymat ic  ac t i v i t y  lournd l  o l  Cc l l  I l i oc l rcnr rs r ry
2 6 :  l 8 l - 1 9 5
Carney  D I I ,  F le rhosa C J ,  S t ic rn t rc rg  l ,  l l c rgnran  S.  ( io r r lon  A,  Scot r
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Czcnd l ik  C,  I : cmnr lc  I ] ,  l )ucker t  F  1985 Co ld  p romoted ac t iva t ion
und lac [ ( ] r  X I l ,  p rcka l l i k re in  and C l - inh ib i to r .  Thrombos is  and
I  lacmostas is  53(2) :  212-241
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th ronrbos is  hv  Lhc  svn ther ic  an [ l rh romhin  o-pheny la lany l - r - -p ro ly l - l -
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unt i t l rn rnrhrn  l l l  rn  L I rc  p rcsuner  ( ) l  cer ta ln  g lvc t rsaminog lycans  found
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coagu la t ion  and th rombogencs is  induccc l  hv  rah t r i t  aor t . r
subcndorhe l ium exposcrJ  to  l lo rv ing  human l r lood :  I l r r l c  o l  dose
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